Activation of sirtuin 1 attenuates cerebral ventricular streptozotocin-induced tau hyperphosphorylation and cognitive injuries in rat hippocampi

[1]  R. Roskoski.  ERK1/2 MAP kinases: structure, function, and regulation. , 2012, Pharmacological research.

[2]  P. Sachdev,et al.  Sirtuins in cognitive ageing and Alzheimer's disease , 2012, Current opinion in psychiatry.

[3]  A. Sinclair,et al.  Diabetes mellitus as a modulator of functional impairment and decline in Alzheimer’s disease. The Real.FR cohort , 2012, Diabetic medicine : a journal of the British Diabetic Association.

[4]  C. Pinkert,et al.  Central insulin resistance and synaptic dysfunction in intracerebroventricular-streptozotocin injected rodents , 2012, Neurobiology of Aging.

[5]  Qing Xu,et al.  Systemic SIRT1 insufficiency results in disruption of energy homeostasis and steroid hormone metabolism upon high‐fat‐diet feeding , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  W. F. Abdo,et al.  CSF α-synuclein does not differentiate between parkinsonian disorders , 2012, Neurobiology of Aging.

[7]  D. Sinclair,et al.  SIRT1 deacetylase in SF1 neurons protects against metabolic imbalance. , 2011, Cell metabolism.

[8]  Ying Liu,et al.  Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes , 2011, The Journal of pathology.

[9]  J. Trojanowski,et al.  The acetylation of tau inhibits its function and promotes pathological tau aggregation. , 2011, Nature communications.

[10]  R. Raffa,et al.  Diabetes mellitus and Alzheimer's disease: shared pathology and treatment? , 2011, British journal of clinical pharmacology.

[11]  E. Yaksi,et al.  Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy , 2010, Neuron.

[12]  L. Guarente,et al.  RETRACTED: SIRT1 Suppresses β-Amyloid Production by Activating the α-Secretase Gene ADAM10 , 2010, Cell.

[13]  I. Grundke‐Iqbal,et al.  Dysregulation of insulin signaling, glucose transporters, O-GlcNAcylation, and phosphorylation of tau and neurofilaments in the brain: Implication for Alzheimer's disease. , 2009, The American journal of pathology.

[14]  Y. Ikeda,et al.  High glucose induces transactivation of the alpha2-HS glycoprotein gene through the ERK1/2 signaling pathway. , 2009, Journal of atherosclerosis and thrombosis.

[15]  D. Bennett,et al.  Sirtuin 1 Reduction Parallels the Accumulation of Tau in Alzheimer Disease , 2009, Journal of neuropathology and experimental neurology.

[16]  Alexander S. Banks,et al.  SirT1 gain of function increases energy efficiency and prevents diabetes in mice. , 2008, Cell metabolism.

[17]  S. Hoyer,et al.  Long-term effects of corticosterone on behavior, oxidative and energy metabolism of parietotemporal cerebral cortex and hippocampus of rats: comparison to intracerebroventricular streptozotocin , 2008, Journal of Neural Transmission.

[18]  Jinping Liu,et al.  Differential expression of the catalytic subunits for PP-1 and PP-2A and the regulatory subunits for PP–2A in mouse eye , 2008, Molecular vision.

[19]  Amy V. Lynch,et al.  Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes , 2007, Nature.

[20]  Andre Fischer,et al.  SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis , 2007, The EMBO journal.

[21]  A. Sima,et al.  Alzheimer-Like Changes in Rat Models of Spontaneous Diabetes , 2007, Diabetes.

[22]  P. Riederer,et al.  Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein , 2007, Journal of neurochemistry.

[23]  Mehrdad Roghani,et al.  Effect of Naringenin on Intracerebroventricular Streptozotocin-Induced Cognitive Deficits in Rat: A Behavioral Analysis , 2006, Pharmacology.

[24]  Jun Wang,et al.  Neuronal SIRT1 Activation as a Novel Mechanism Underlying the Prevention of Alzheimer Disease Amyloid Neuropathology by Calorie Restriction* , 2006, Journal of Biological Chemistry.

[25]  G. Biessels,et al.  Synaptic transmission changes in the pyramidal cells of the hippocampus in streptozotocin-induced diabetes mellitus in rats , 2006, Brain Research.

[26]  P. Riederer,et al.  Alzheimer‐like changes in protein kinase B and glycogen synthase kinase‐3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway , 2006, Journal of neurochemistry.

[27]  L. Jing,et al.  Hyperglycemia increased brain ischemia injury through extracellular signal-regulated protein Kinase. , 2006, Pathology, research and practice.

[28]  M. W. Roos,et al.  Experimental treatment for focal hyperglycemic ischemic brain injury in the rat , 2005, Experimental Brain Research.

[29]  Wilhelm Haas,et al.  Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1 , 2005, Nature.

[30]  Tian-Le Xu,et al.  The neuroprotective action of SP600125, a new inhibitor of JNK, on transient brain ischemia/reperfusion-induced neuronal death in rat hippocampal CA1 via nuclear and non-nuclear pathways , 2005, Brain Research.

[31]  Wen-zheng Chu,et al.  [Expressions of Abeta1-40, Abeta1-42, tau202, tau396 and tau404 after intracerebroventricular injection of streptozotocin in rats]. , 2005, Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA.

[32]  J. Heijnen,et al.  Analysis of in vivo kinetics of glycolysis in aerobic Saccharomyces cerevisiae by application of glucose and ethanol pulses , 2004, Biotechnology and bioengineering.

[33]  J. Milbrandt,et al.  Increased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration , 2004, Science.

[34]  D. Bennett,et al.  Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. , 2004, Archives of neurology.

[35]  B. Siesjö,et al.  Hyperglycemia and hypercapnia differently affect post-ischemic changes in protein kinases and protein phosphorylation in the rat cingulate cortex , 2004, Brain Research.

[36]  C. Ding,et al.  Effects of hyperglycemic and normoglycemic cerebral ischemia on phosphorylation of c-jun NH2-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK). , 2003, Cellular and molecular biology.

[37]  B. Winblad,et al.  Okadaic-acid-induced inhibition of protein phosphatase 2A produces activation of mitogen-activated protein kinases ERK1/2, MEK1/2, and p70 S6, similar to that in Alzheimer's disease. , 2003, The American journal of pathology.

[38]  H. Braak,et al.  Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease. , 2002, Brain research. Molecular brain research.

[39]  D. Khaitan,et al.  Low-Dose Radiation Hypersensitivity in Human Tumor Cell Lines: Effects of Cell–Cell Contact and Nutritional Deprivation , 2002, Radiation research.

[40]  G. Biessels,et al.  Effects of streptozotocin‐diabetes on the hippocampal NMDA receptor complex in rats , 2002, Journal of neurochemistry.

[41]  M. Moskowitz,et al.  Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[42]  B. Siesjö,et al.  Phosphorylation of Extracellular Signal-Regulated Kinase after Transient Cerebral Ischemia in Hyperglycemic Rats , 2001, Neurobiology of Disease.

[43]  S. Hoyer,et al.  Inhibition of the Neuronal Insulin Receptor An in Vivo Model for Sporadic Alzheimer Disease? , 2000, Annals of the New York Academy of Sciences.

[44]  R. Stewart,et al.  Type 2 diabetes mellitus, cognitive impairment and dementia , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[45]  G. Massicotte,et al.  Binding Properties of Glutamate Receptors in Streptozotocin-Induced Diabetes in Rats , 1997, Diabetes.

[46]  G. Biessels,et al.  Insulin partially reverses deficits in peripheral nerve blood flow and conduction in experimental diabetes , 1996, Journal of Neurological Sciences.

[47]  G. Biessels,et al.  Place Learning and Hippocampal Synaptic Plasticity in Streptozotocin-Induced Diabetic Rats , 1996, Diabetes.

[48]  M. Gillum,et al.  Sirtuin-1 regulation of mammalian metabolism. , 2011, Trends in molecular medicine.

[49]  P. Riederer,et al.  Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice. , 2010, Journal of Alzheimer's disease : JAD.

[50]  S. Hoyer,et al.  Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach. , 2007, Journal of neural transmission. Supplementum.

[51]  J. Wands,et al.  Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes? , 2005, Journal of Alzheimer's disease : JAD.

[52]  R. Nitsch,et al.  Cerebral excess release of neurotransmitter amino acids subsequent to reduced cerebral glucose metabolism in early-onset dementia of Alzheimer type , 2005, Journal of Neural Transmission.

[53]  Steven P Gygi,et al.  Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. , 2005, Nature.

[54]  H. Tjälve,et al.  Distrubution and metabolism in syrian golden hamsters of 4=(methylnitrosamino)=1=(3=pyridyl)=1= butanone (NNK), a tebacco-specific careinogen , 1983 .

[55]  H. Tjälve,et al.  Distribution and metabolism in Syrian golden hamsters of 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific carcinogen. , 1983, Developments in toxicology and environmental science.